Cargando…

757 Comparison of Nephrotoxicity in Outpatient Parenteral Antimicrobial Therapy (OPAT) Patients Receiving Beta-lactams or Vancomycin

Detalles Bibliográficos
Autores principales:	Streifel, Amber, Felder, Kimberly, Taylor, Jerusha, Barnes, Penelope
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2014
Materias:	IDWeek 2014 Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781538/ http://dx.doi.org/10.1093/ofid/ofu052.465

Ejemplares similares

1298 Predictors of Hospital Readmission in Patients Receiving Outpatient Parenteral Antimicrobial Therapy (OPAT)
por: Means, Laura, et al.
Publicado: (2014)

758 Treatment Complications During Outpatient Parenteral Antimicrobial Therapy (OPAT) Administered at Home
por: Shrestha, Nabin, et al.
Publicado: (2014)

751 Outpatient Parenteral Antimicrobial Therapy (OPAT) Outcomes at a Tertiary Care Hospital
por: Shrestha, Nabin, et al.
Publicado: (2014)

756 Emergency Department Visits During Outpatient Parenteral Antimicrobial Therapy (OPAT) Administered at Home
por: Shrestha, Nabin, et al.
Publicado: (2014)

1301 Outpatient Parenteral Antimicrobial Therapy (OPAT) in Intravenous Drug Users (IVDUs): Epidemiology and Outcomes
por: Papalekas, Eleni, et al.
Publicado: (2014)

760 Piperacillin/Tazobactam-Induced Adverse Drug Events in Pediatric Patients on Outpatient Parenteral Antimicrobial Therapy (OPAT)
por: Yusef, Dawood, et al.
Publicado: (2014)

764 Risk Factors for Failure of Outpatient Parenteral Antimicrobial Therapy (OPAT) in the Management of Staphylococcus aureus Bacteremia (SAB)
por: Veillette, John, et al.
Publicado: (2014)

748 Outpatient Parenteral Antimicrobial Therapy (OPAT) with Continuous Infusions by Elastomeric Infusion Devices in Japan, as an Effective Tool for Better Antimicrobial Stewardship
por: Hase, Ryota, et al.
Publicado: (2014)

762 Outpatient Parenteral Antimicrobial Therapy (OPAT) Treatment Center as Part of Integrated Care Delivery – Single-Center Experience from the First Three Years of Operation
por: Bochan, Markian, et al.
Publicado: (2014)

745 Risk of Peripheral Blood Eosinophilia and Hypersensitivity Reactions among Patients Receiving Outpatient Parenteral Antibiotics
por: Blumenthal, Kimberly, et al.
Publicado: (2014)

396 What is the Best Predictor for Vancomycin Nephrotoxicity?
por: Hammoud, Kassem, et al.
Publicado: (2014)

1300 OPAT Administration in the Homeless Population
por: Hernandez, Whitney, et al.
Publicado: (2014)

Utilizing a Post-discharge Telephone Call in Outpatient Parenteral Antimicrobial Therapy (OPAT): Findings from a Quality Improvement Project
por: Felder, Kimberly, et al.
Publicado: (2017)

755 Comparison of Outpatient Antimicrobial Therapy (OPAT) in a Physician Office Infusion Center (POIC) vs Traditional Home Health Care (HHC)
por: Prokesch, Richard C., et al.
Publicado: (2014)

740 Hospital Avoidance Utilizing an ID Supervised OPAT Program
por: Skorodin, Nathan, et al.
Publicado: (2014)

610. Incidence of Acute Kidney Injury in Outpatient Parenteral Antimicrobial Therapy (OPAT) Patients Receiving Vancomycin
por: Hamad, Yasir, et al.
Publicado: (2020)

761 A Comparison of Outpatient Parenteral (OP) Antibiotic Therapy (AT) Outcomes: Physician Office and Home Based Therapy
por: O'neill, Donna, et al.
Publicado: (2014)

Comparison of Outcomes in Outpatient Parenteral Antimicrobial Therapy (OPAT) Patients Receiving Vancomycin vs. Non-Vancomycin Anti-MRSA Therapy
por: Stoneking, Carolyn, et al.
Publicado: (2017)

750 Effectiveness, Safety, and Impact on Healthcare Decongestion by a Busy Canadian Infusion Centre for Outpatient Parenteral Antimicrobial Therapy
por: Afra, Kevin, et al.
Publicado: (2014)

728 Evaluation of Empirical Regimens Including Antistaphylococal Beta-lactam Antibiotics vs Vancomycin Monotherapy on Outcomes of Patients with Methicillin-Susceptible Staphylococcus aureus (MSSA) Bacteremia
por: Terico, Adrienne, et al.
Publicado: (2014)

1636 Low Incidence Of Clostridium Difficile Infection (CDI) in Patients Treated with Community Outpatient Parenteral Antimicrobial Therapy (CoPAT)
por: Wong, Ken Koon, et al.
Publicado: (2014)

753 Does Electronic Medication Reconciliation at Hospital Discharge Curb Distracted Prescribing for Outpatient Parenteral Antibiotic Therapy? A Pilot Study
por: Weigel, Bernard, et al.
Publicado: (2014)

OPAT: outpatient parenteral antimicrobial therapy
Publicado: (2020)

288 Lack of Synergy With Six Blood Isolates of Methicillin-Resistant Staphylococcus aureus (Vancomycin MIC of 2) Tested With Combinations of Vancomycin + Gentamicin, Vancomycin + Rifampin and Vancomycin + Cefazolin.
por: Long, Virginia, et al.
Publicado: (2014)

673 Comparative Effectiveness of Vancomycin vs Early Daptomycin for MRSA Bacteremia with Vancomycin MIC >1 mg/L: A Multicenter Evaluation
por: Moise, Pamela, et al.
Publicado: (2014)

393 Vancomycin Dosing in Obese Patients
por: Alquwaizani, Mohammed, et al.
Publicado: (2014)

1652 Retrospective Comparision of Oral Vancomycin Capsules vs Oral Vancomycin Solution for the Treatment of Severe Clostridium Defficile Infection
por: Saleh, Rania, et al.
Publicado: (2014)

1923. OPAT or No-PAT? Evaluation of Outpatient Parenteral Antimicrobial Therapy (OPAT) Patients Receiving Daptomycin or Ertapenem for “Ease of Administration”
por: Britt, Rachel S, et al.
Publicado: (2018)

597. Comparison of Vancomycin and Daptomycin Complications and Interventions in Outpatient Parenteral Antimicrobial Therapy
por: Nakrani, Monark, et al.
Publicado: (2020)

280 Association between acessory gene regulator II expression and mortality among critically ill patients receiving vancomycin for hospital-acquired methicillin-resistant Staphylococcus aureus bacteremia
por: Rosa, Regis, et al.
Publicado: (2014)

675 Outcomes of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) by vancomycin dosing regimen and vancomycin trough serum concentrations in the DISCOVER Program
por: Puttagunta, Sailaja, et al.
Publicado: (2014)

1925. Vancomycin Treatment and Time to Adverse Drug Reactions During Outpatient Parenteral Antimicrobial Therapy (OPAT)
por: Duncan, Asajah, et al.
Publicado: (2018)

485 Colistin Nephrotoxicity in Critically Ill Patients after Implementation of a New Dosing Strategy
por: Özel, Ayşe Serra, et al.
Publicado: (2014)

1796 Recovery of Clostridium difficile, Vancomycin Resistant Enterococcus and Methicillin Resistant Staphylococcus aureus from the Food of Hospitalized Patients
por: Kwon, Jennie H., et al.
Publicado: (2014)

394 Influence of febrile neutropenia on the pharmacokinetics and dosage requirements of vancomycin
por: Shiotsuka, Shouichi, et al.
Publicado: (2014)

716 Risk Factors for Resistance to Beta-lactam/Beta-lactamase Inhibitors and Carbapenems in Bacteroides spp. Bacteremia
por: Smith, Janessa, et al.
Publicado: (2014)

Outpatient parenteral antibiotic therapy (OPAT) for the management of bronchiectasis
por: Tu, Jacky, et al.
Publicado: (2023)

474 Ceftaroline Salvage Therapy for MRSA Bacteremia Following Vancomycin Failure
por: Pettit, Natasha, et al.
Publicado: (2014)

733 Vancomycin-Resistant Enterococcus (VRE) faecium Bloodstream Infections and Mortality
por: Suleyman, Geehan, et al.
Publicado: (2014)

688 The Effect of Preoperative Vancomycin on Bacteria Isolation from Operative Cultures
por: Young, Heather, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_89bggq8iv68pa09hj6qffsb14t